AwesomeCapital

Search This Blog

Friday, September 10, 2021

Newsom Opposed Vaccine Mandates Just Two Years Ago; Biden And Fauci Also Said 'No'

 A common mistake people make is assuming the lying liar isn't lying this time.

For example, Joe Biden and Anthony Fauci have both previously said they wouldn't require, or 'couldn't see' a Covid-19 vaccine mandate in the United States.


And as recently as July...

Now, Human Events' Jack Posobiec reveals that California Governor Gavin Newsom - who's essentially campaigning against his recall on mandatory vaccinations - had deep reservations over government officials 'making a decision that is very personal.'

Read:

California Gov. Gavin Newsom announced in July that healthcare workers and state employees must be vaccinated or succumb to weekly testing and wear masks; however, back in 2019, Newsom opposed the same kind of mandate. 

“I believe in immunizations,” Newsom said at the meeting, “however I do legitimately have concerns about a bureaucrat making a decision that is very personal.” 

“We don’t measure character or leadership by a commander’s posture during moments of comfort, but by his willingness to stand against the tides and storms of collective opinion during eras of controversy and hysteria,” Kennedy Jr. wrote in a Facebook post. “California Gov. Gavin Newsom has just passed that test with his wise and sober opposition to a draconian proposal to forcibly vaccinate medically fragile children against the wishes of their parents and the medical advice of their physician.” 

“He expressed his concern about giving faceless government officials (with no medical training) veto power over vaccine exemptions deemed medically necessary by a child’s doctor,” Kennedy Jr. continued. “Gavin argued that those decisions should be made between patients and doctors without government involvement.”

https://www.zerohedge.com/political/gavin-newsom-opposed-vaccine-mandates-just-two-years-ago-biden-and-fauci-also-said-no
Posted by AwesomeCapital at 7:30 AM
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)

Blog Archive

  • ►  2026 (1934)
    • ►  February (79)
    • ►  January (1855)
  • ►  2025 (20273)
    • ►  December (1706)
    • ►  November (1621)
    • ►  October (1859)
    • ►  September (1690)
    • ►  August (1714)
    • ►  July (1681)
    • ►  June (1631)
    • ►  May (1558)
    • ►  April (1590)
    • ►  March (1900)
    • ►  February (1547)
    • ►  January (1776)
  • ►  2024 (17567)
    • ►  December (1320)
    • ►  November (1464)
    • ►  October (1549)
    • ►  September (1529)
    • ►  August (1674)
    • ►  July (1415)
    • ►  June (1247)
    • ►  May (1442)
    • ►  April (1409)
    • ►  March (1422)
    • ►  February (1406)
    • ►  January (1690)
  • ►  2023 (17794)
    • ►  December (1359)
    • ►  November (1422)
    • ►  October (1490)
    • ►  September (1167)
    • ►  August (1472)
    • ►  July (1639)
    • ►  June (1628)
    • ►  May (1654)
    • ►  April (1632)
    • ►  March (1284)
    • ►  February (1632)
    • ►  January (1415)
  • ►  2022 (14151)
    • ►  December (1397)
    • ►  November (1235)
    • ►  October (1311)
    • ►  September (1135)
    • ►  August (1066)
    • ►  July (1047)
    • ►  June (1022)
    • ►  May (1196)
    • ►  April (1190)
    • ►  March (1236)
    • ►  February (1054)
    • ►  January (1262)
  • ▼  2021 (11137)
    • ►  December (1167)
    • ►  November (958)
    • ►  October (643)
    • ▼  September (775)
      • AstraZeneca COVID-19 Jab Shows 74% Efficacy In US ...
      • How nanomaterial aids antibody response
      • Why some people are less naturally resistant to CO...
      • DHS concerned about potential border surge if COVI...
      • 1/3 of parents want to vaccinate 5- to 11-year-old...
      • Troops move to block Pentagon vaccine requirement ...
      • NYC teachers ask Supreme Court to block vaccine ma...
      • Gilead's Kite Applies to FDA for Earlier Use of Ye...
      • FDA posts guidance on mining real-world data from ...
      • Glaxo $4.2B bet on Merck KGaA cancer drug goes up ...
      • Regeneron's Covid-19 antibody gets an in-patient b...
      • Editas falls well short of Brilliance
      • AngioDynamics Reports Fiscal 2022 Q1 Results; Upda...
      • Alzamend Neuro: Positive Pre-IND FDA Response for ...
      • Perrigo Stock Soars After Settling Irish Tax Dispute
      • OptimizeRx Set to Join S&P SmallCap 600
      • DiaMedica Fast Tracked for the Treatment of Acute ...
      • Lilly, Incyte : Olumiant Superior to Placebo in Sc...
      • Regeneron Covid-19 Trial Meets Primary Endpoint
      • Merck to buy Acceleron for about $11.5 billion in ...
      • Bausch: Significant Top Line Results in 2nd Dry Ey...
      • Trevena: Positive Results in Proof-of-Concept Stud...
      • TG Therapeutics Files with FDA for MS Treatment
      • 37% of COVID patients deal with at least 1 long-te...
      • Revenue cycle management platform Ensemble Health ...
      • Health and wellness SPAC Thrive Acquisition cuts d...
      • Inflammatory disease biotech Ventyx Biosciences fi...
      • I-Mab hits the deal table with biopharma majors to...
      • Amicus spins off gene therapy unit in $600M SPAC d...
      • CytoDyn Comments on Rosenbaum/Patterson Activist G...
      • Lilly upped to Buy from Neutral by Citi
      • GeoVax Higher On Gedeptin In-Licensing Pact For So...
      • Why Shares of Editas Medicine Are Lower
      • Evolent Health stock jumps after report of possibl...
      • Merck's reported $11B Acceleron buy could help it ...
      • In preclinical tests, Merck’s COVID-19 antiviral s...
      • J&J Starts Phase 3 Trial for RSV Vaccine in Older ...
      • NuCana Soars as FDA Fast Tracks Potential Drug for...
      • FDA Expands Lilly Erbitux Label With Braftovi For ...
      • AstraZeneca to Buy Remaining Stake in Caelum Biosc...
      • FDA leaning toward approving Moderna half-dose boo...
      • COVID-19 pill developers aim to top Merck, Pfizer ...
      • Biden's Vax Mandate To Be Enforced By Fining Compa...
      • US To Exclude Travelers Vaccinated With Russia's S...
      • Steroid nasal sprays may help improve outcomes in ...
      • Study suggests R rate for tracking pandemic should...
      • Vaccination guards against certain bacterial infec...
      • ViiV Gets FDA Priority Review for Cabotegravir Lon...
      • Teva Pharma Shares Up 6% After Louisiana Opioid Se...
      • AbbVie Says FDA Approves Qulipta as Migraine Treat...
      • H.C. Wainwright Sees Buying Opportunity In Biotech...
      • Vaccination pace is largest but hardly only drag o...
      • Unvaccinated Americans say need for booster shots ...
      • Federal Judges: NYC Can Impose Vaccine Mandate on ...
      • Sorry, Employers: Vax Mandate Battle Is Just Begin...
      • England’s cancer therapy backlog ‘could take more ...
      • Pfizer submits trial data for kids COVID-19 vaccin...
      • Initial Clinical Data from Editas Medicine Retinal...
      • JPMorgan Concludes That Delta Variant Was 'Less In...
      • Altimmune slims down on side-effect concerns
      • Eisai files, and the sellside endorses the Alzheim...
      • Over 400,000 in US got Covid booster at pharmacies...
      • FDA official Marks taking on responsibilities to l...
      • Majority in new poll distrusts Biden on COVID-19
      • NY governor signs emergency order addressing poten...
      • Evelo Biosciences Psoriasis Candidate Shows Benefi...
      • Valneva, Pfizer Phase 2 Data Suggests Booster Stra...
      • Eisai, Biogen start U.S. accelerated approval for ...
      • Puma Biotech upped to Buy from Neutral by Citi
      • Harpoon Therapeutics upped to Buy from Neutral by ...
      • Sanofi ditches mRNA COVID-19 vaccine after rivals'...
      • FDA OKs Regeneron Libtayo for Priority Review for ...
      • Ocugen-Partnered Covaxin's WHO Clearance Delayed F...
      • Pfizer submits data for COVID-19 vaccine use in yo...
      • Lilly to cut price of Lispro insulin injection by ...
      • Impel NeuroPharma launches migraine nasal spray
      • AIM ImmunoTech Submits Pre-IND Application for Pha...
      • Altimmune: 'Positive Results in 12-week Phase 1 Ob...
      • Sonoma Pharma Launches 1st OTC Products in U.S. on...
      • Arrowhead Earns $10 Million Phase 1 Milestone Payment
      • Stealth Bio: Positive Data in Pediatric Cardiology...
      • Lawyers, Scientists Build Case for Natural Immunit...
      • NY Gov Confirms National Guard Will Fill In For Fi...
      • Mechanics of drug targets for COVID-19
      • Benefits of early intervention in autoimmune diseases
      • Creating 'elite' antibodies to keep up with pandem...
      • Merck in advanced talks to buy Acceleron Pharma
      • Biden administration wants scientific advisers. It...
      • Biden, Democrats may limit free college, childcare...
      • Altimmune to Announce 12-Week Data on Obesity Med ...
      • Paratek Gets Added BARDA Funding for Anthrax Treat...
      • Biogen used charity giving to illegally boost MS d...
      • Pfizer Starts Study of mRNA-Based Next Generation ...
      • Incyte turns to in-licensing
      • Aslan fails to roar with atopic dermatitis data
      • Stimulant Reduces Apathy in Alzheimer's
      • Pacific Biosciences started at Buy by Canaccord
      • Novo Nordisk smartens disposable insulin pens with...
      • Amgen Repatha gains on rival Praluent with FDA OK ...
      • Small study shows antibody growth from AstraZeneca...
    • ►  August (884)
    • ►  July (919)
    • ►  June (871)
    • ►  May (975)
    • ►  April (1061)
    • ►  March (1038)
    • ►  February (881)
    • ►  January (965)
  • ►  2020 (12053)
    • ►  December (902)
    • ►  November (768)
    • ►  October (872)
    • ►  September (806)
    • ►  August (854)
    • ►  July (980)
    • ►  June (1046)
    • ►  May (1218)
    • ►  April (1258)
    • ►  March (1293)
    • ►  February (1041)
    • ►  January (1015)
  • ►  2019 (14242)
    • ►  December (897)
    • ►  November (1053)
    • ►  October (1052)
    • ►  September (898)
    • ►  August (1149)
    • ►  July (1154)
    • ►  June (1070)
    • ►  May (1349)
    • ►  April (1303)
    • ►  March (1220)
    • ►  February (1497)
    • ►  January (1600)
  • ►  2018 (9593)
    • ►  December (1246)
    • ►  November (1211)
    • ►  October (1284)
    • ►  September (1206)
    • ►  August (1337)
    • ►  July (1092)
    • ►  June (1237)
    • ►  May (956)
    • ►  April (24)
Simple theme. Powered by Blogger.